Status of α-emitter Radioimmunoconjugates for Targeted Therapy

被引：0
|
作者：
Mobina, Rabiei [1 ]
Alaei, Ahmad Reza Vaez [2 ]
Yousefnia, Hassan [3 ]
机构：
[1] Islamic Azad Univ, Nucl Engn Sch, Shahrood Branch, Shahrud, Iran
[2] Islamic Azad Univ, Parand Branch, Fac Sci, Tehran, Iran
[3] Nucl Sci & Technol Res Inst NSTRI, Radiat Applicat Res Sch, Tehran, Iran
来源：
CURRENT RADIOPHARMACEUTICALS | 2023年 / 16卷 / 02期
关键词：
& alpha; -emitters; radio; immunotherapy; immunoconjugates; bifunctional ligands; trials; MONOCLONAL-ANTIBODY; IN-VITRO; ALPHA-RADIOIMMUNOTHERAPY; MURINE MODEL; CANCER; ASTATINE-211; DOSIMETRY; FRAGMENTS; LYMPHOMA; F(AB')2;
D O I：
10.2174/1874471016666230106111119
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
This minireview describes the global situation of ongoing research and development and the clinical application of alpha emitter labeled immunoconjugates with various alpha emitters with an overview of the future trends. The potentially helpful alpha emitter radioisotopes for medical applications, chelators, and immunomolecules of interest for future alpha radioimmunotherapy are discussed. Challenges and some suggested future works on chelators are also presented.
引用
收藏
页码：85 / 94
页数：10
相关论文
共 50 条
  • [1] National Cancer Institute support for targeted alpha-emitter therapy
    Hong, Julie A.
    Brechbiel, Martin
    Buchsbaum, Jeff
    Canaria, Christie A.
    Coleman, C. Norman
    Escorcia, Freddy E.
    Espey, Michael
    Kunos, Charles
    Lin, Frank
    Narayanan, Deepa
    Capala, Jacek
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 49 (01) : 64 - 72
  • [2] Targeted therapy in ophthalmic oncology: The current status
    Sen, Mrittika
    Demirci, Hakan
    Honavar, Santosh G.
    ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY, 2024, 13 (02):
  • [3] Production and dosimetric aspects of the potent Auger emitter 58mCo for targeted radionuclide therapy of small tumors
    Thisgaard, H.
    Elema, D. R.
    Jensen, M.
    MEDICAL PHYSICS, 2011, 38 (08) : 4535 - 4541
  • [4] Targeted Therapy With Immunoconjugates for Multiple Myeloma
    Bruins, Wassilis S. C.
    Zweegman, Sonja
    Mutis, Tuna
    van de Donk, Niels W. C. J.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [5] Review of current status of targeted alpha therapy in cancer treatment
    Jabbar, Tania
    Bashir, Sajid
    Imran, Muhammad Babar
    NUCLEAR MEDICINE REVIEW, 2023, 26 : 54 - 67
  • [6] 119Sb -: A potent Auger emitter for targeted radionuclide therapy
    Thisgaard, H.
    Jensen, M.
    MEDICAL PHYSICS, 2008, 35 (09) : 3839 - 3846
  • [7] Therapy of B-cell lymphomas with monoclonal antibodies and radioimmunoconjugates: the Seattle experience
    T. A. Johnson
    O. W. Press
    Annals of Hematology, 2000, 79 : 175 - 182
  • [8] Therapy of B-cell lymphomas with monoclonal antibodies and radioimmunoconjugates: the Seattle experience
    Johnson, TA
    Press, OW
    ANNALS OF HEMATOLOGY, 2000, 79 (04) : 175 - 182
  • [9] Current Status and Prospects of Targeted Therapy for Osteosarcoma
    Hu, Zunguo
    Wen, Shuang
    Huo, Zijun
    Wang, Qing
    Zhao, Jiantao
    Wang, Zihao
    Chen, Yanchun
    Zhang, Lingyun
    Zhou, Fenghua
    Guo, Zhangyu
    Liu, Huancai
    Zhou, Shuanhu
    CELLS, 2022, 11 (21)
  • [10] High molecular mass radioimmunoconjugates are promising for intraperitoneal α-emitter immunotherapy due to prolonged retention in the peritoneum
    Rauch, Christian
    Seidl, Christof
    Schlapschy, Martin
    Skerra, Arne
    Morgenstern, Alfred
    Bruchertseifer, Frank
    Senekowitsch-Schmidtke, Reingard
    NUCLEAR MEDICINE AND BIOLOGY, 2012, 39 (05) : 617 - 627
12345